earn qualiti drive materi out-performance confer
underappreci valuat benefit top tier compani
convers pace scale slow wake
still drive under-perform bd
earn qualiti trend improv year deterior sinc
median level convers net incom adjust net
incom fallen pt pt respect see exhibit much
deterior attribut scale result one-tim charg
amort build-up impair total total non-gaap
adjust past year note compani analysi
undertaken materi deal past year skew
report qualiti seventh annual earn qualiti analysi report
qualiti ni adj ni improv pt second consecut year
trough revers steadi declin sinc improv
mainli driven anniversari tax adjust larger charg
convers declin pt line
averag sinc declin primarili attribut
idiosyncrat factor includ one time item impact cash flow assum
major shift regulatori polici appear immin see
ni convers convers new normal
analysi yield three key conclus stock move implic
averag score prevail outperform bottom tier
compani lowest averag score prevail pt
analysi compani top tier new except edward
top tier year vs prior improv
sustain cash convers non-gaap adjust
vs prior anniversari neotract drove materi
improv earn sustain vs prior improv
lowest rank sinc tax charg actelion weigh metric
bottom tier rel consist add-back restructur
weigh qualiti boston avano zimmer biomet
haemonet rank bottom last four
year exhibit earn qualiti rank exhibit
rank trend past sever year
 drive under-perform scale activ declin
residu impact continu drive non-gaap adjust sever larger scale
acquisit announc continu pronounc impact
appreci support
institut investor all-america
research survey request ballot
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
relat amort impair adjust causal
perfect would note bd bard cynosur
under-perform devic averag point sinc transact
continu make signific earn adjust relat
deal continu question logic transform prefer
vertic driven transact see heighten scrutini non-gaap measur
detail
qualiti adjust obscur valuat us strategi
account team construct modifi pro forma earn number
add back non-recur item found consist
superior predictor company-report pro forma metric
last year use similar methodolog examin valuat across
coverag includ non-cash expens amort stock comp
coverag back adjust number result elev
median price-to-earnings multipl impli coverag would appear
expens exampl zimmer biomet
expens would predict consensu
edward globu grifol would line would
predict see investor detail
exhibit depict company-specif impact
purpos earn qualiti analysi investor percept compani capac
sustain grow ep drive stock multipl yet investor depend larg
company-report financi statement form expect ep growth earn
qualiti analysi assess extent compani report financi provid
sound basi forecast futur perform analysi includ in-depth
analysi cover compani exclud axon
irhythm shockwav given lack limit profit
past five year exclud alcon due limit histori report
long-term widen disconnect earn adjust earn
cash flow suggest investor scrutin report result close
earn qualiti metric deterior level
median net incom adjust net incom median
convers disconnect moder
convers revert back downward two metric still
fallen dramat past year current sit
number factor contribut widen gap
adjust net incom net incom includ adopt
cash ep larger scale restructur
exhibit report qualiti convers ratio declin
compani data thomson reuter morgan stanley research note compani includ vari year given number factor
convers cash ep present complet med-tech compani
includ earn qualiti analysi convert cash ep
lone compani report cash ep given neglig amort would
impact edward last large-cap convert earli globu
last compani convert mid-way follow alphatec
acquisit ep report gener take account
amort expens may reduc perceiv cost pursu less
preval med-tech cash ep report may also exclud stock compens
expens ep revolut taken place section addit
non-gaap focu sec wane follow concern non-gaap
measur pro forma adjust coupl year ago said focu return
action taken could relev med-tech compani heighten
scrutini non-gaap measur section inform
constant restructur acquisit across space recent
year potenti sec could disagre back
expens compani serial restructur acquir
ep look like liquid measur liquid measur allow
shown per-shar basi possibl sec could pushback
measur potenti requir compani disclos gross adjust valu
rather per share valu
sec prevent use cash ep metric knowledg
action aggreg compani would optic appear
expens weight averag median impact
scenario would zimmer biomet bd abbott
least impact would globu grifol edward
exhibit look forma modifi forma ep multipl across coverag
price earn multipl ep
morgan stanley research compani data note impact amort stock compens calcul tax rate across
compani consist
note price
valuat spread consensu estim widen
qualiti estim may import differenti multipl
consensu number look cash flow instead earn may offer solut
forward year price earn multipl coverag widen
current coverag price-to-earnings multipl within coverag
median figur
even wider rang valuat p/fcf basi
coverag fall within rang median
qualiti rank leader laggard outlier
metric reflect last complet fiscal year compani analysi
exhibit overal qualiti rank year
metric reflect last complet fiscal year compani analysi
qualiti rank prior earn qualiti report found appendix
ep prefer metric fair implement transpar
account
larg amort burden artifici depress earn rel
remov amort penalti may incentiv compani low-
compani want adopt cash ep believ owe sharehold
addit transpar account respect
manag transpar sharehold evalu need move beyond
ep accret never perfect metric lose much valid
amort exclud ii low cost debt financ avail
addit metric irr payback period may help
investor less subject bia
compani start talk altern metric
disclosur remain imprecis qualit prefer precis quantit
compani move cash ep assum addit respons sharehold
 justifi comparison capit deploy possibl
organ reinvest dividend share repurchas
execut compens polici align non-ep metric
organ revenu growth
convers cash ep acceler last year includ
compani current back amort includ compani
report cash ep howev import note amort expens
nuvas septemb follow acquisit technolog asset
novemb follow increas activ cytyc
deal announc may
april anticip acceler activ pursuant
abbott april follow separ
intuit surgic juli conjunct remov stock comp
avano formerli halyard octob follow spin kimberli
edward januari follow cardiaq match industri report
heighten scrutini non-gaap measur
non-gaap focu sec wane follow concern non-gaap
measur pro forma adjust year ago offici sec crack
use non-gaap measur bloomberg discuss topic accord morgan
stanley tax account polici analyst todd castagno snehaja mogr sec
primarili concern
adjust revenu earn chang defer revenu
adjust remov normal cash oper expens
per-shar perform measur substanti similar liquid
measur
adjust remov normal cash oper expens per-shar perform
measur look like liquid measur two largest impact
constant restructur acquisit across space recent
year still potenti sec could disagre back
expens compani serial restructur serial acquir
ep readili adopt space see ep revolut
taken place look like liquid measur liquid measur
allow shown per-shar basi note think compani
hesit call adjust metric cash ep possibl sec push
back measur potenti requir compani disclos gross
adjust valu rather per share valu
author materi act capac attorney hold
materi intend either legal opinion legal
advic inform provid herein provid possibl outcom
probabl outcom result legal disput controversi depend
varieti factor includ limit parti histor relationship law
pertain case rel litig talent trial locat juri composit judg
composit investor contact legal advisor issu law relat
subject matter materi
nearli cover compani back restructur charg
difficult us determin charg truli one-tim natur
rather part compani busi model attempt point
compani stand us
haemonet repeat restructur cost account largest
proport adjust net incom signific charg past five year
haemonet back restructur estim earn
would lower
avano formerli halyard also signific restructur cost could
classifi one-tim natur given spin
compani notabl amount restructur activ past
five year includ baxter bd hill-rom would impact
estim earn
vast major cover compani adjust charg larger scale
deal continu residu impact qualiti
compani notabl one-tim relat expens past
sever year includ zimmer biomet avano bd abbott vast
major add-back relat larger potenti
transform deal lead us believ one-tim
respect individu deal acquisit announc
pronounc impact relat amort
impair charg
abbott st jude aler charg abbott
record relat charg amort mainli relat
st jude aler compris non-gaap adjust
bd bard bd non-gaap adjust includ add-back
bard mainli purchas account adjust includ amort
doubl ii inventori step-up iii restructur litig cost
 cynosur includ impair charg result
compani cynosur acquisit charg continu
acquisit cost suggest report qualiti remain averag
 actelion record signific amort charg
respect attribut actelion addit increas
amort compani cite actelion relat charg
year adjust total non-gaap adjust
compani fewest relat adjust past five year
globu
discuss see med-tech chang custom evolut
revolut continu question logic transform
prefer vertic driven transact see exhibit exhibit exhibit
outlin rel total return sever transform transact within
coverag
exhibit depth bundl within categori grow import
exhibit breadth bundl across depart tougher
note rel perform parent vs equip suppli index
us strategi account team explor grow differ
earn pro forma earn construct metric modifi pro forma
earn seek add back non -recur item thu leav
amort stock comp pro forma number
found price-to-earnings multipl base metric consist superior
factor efficaci company-report pro forma metric
last year see america insight gaap gap matter
ltm earn modifi pro forma earn current lower
exhibit modifi forma ltm earn lower forma
sec prevent use cash ep metric knowledg
action aggreg compani would optic appear
largest impact scenario would
inclus amort would lower adjust ep
next wave larg impact would abbott bd zimmer biomet
would impact adjust ep includ amort
boston hill-rom would see impact adjust ep
edward globu grifol intuit surgic impact
amort limit risk ep reduct
report cash ep longer allow would expect uptick write-down
charg intang past deal
exhibit look forma modifi forma ep multipl across coverag
price earn multipl ep
morgan stanley research compani data note impact amort stock compens calcul tax rate across
compani consist
note price
non-gaap adjust creat equal certain one-tim adjust
account chang tax reform back adjust figur
acut last year compani analysi adjust impact us tax
reform remeasur defer tax asset liabil ii recogn tax
associ repatri remain compani report calendar
year cycl adjust impact fiscal year convers adjust
restructur initi appropri reccur natur
materi impact adjust earn notabl
estim earn would lower without restructur add-back
among compani recogn impact tax reform four
compani posit impact earn tax reform
nine neg impact
remain compani adjust impact
new account rule impact minor equiti invest valu
revenu recogn could also drive non-gaap adjust
transpar report conservat aggreg score
rational compani across coverag space use wide varieti assumpt
calcul non-gaap earn number investor tend consid
heavili earn figur give higher qualiti rank compani use
less signific adjust report figur
metric use measur compani cumul gaap net incom
percentag report adjust net incom higher level impli conserv
potenti analysi pitfal non-gaap adjust reason
other defer ad hoc judgment adjust appropri simpli
measur level adjust
convers aggreg score
rational ultim investor want earn number accur reflect
compani underli econom state compani use signific adjust
nonetheless close match cash flow penal calcul
metric use calcul cumul free percentag
potenti analysi pitfal compani fund growth rather organ
capit expenditur may appear higher level actual avail
requir reinvest
earn sustain aggreg score
rational earn qualiti conservat cash flow tri
quantifi like current earn continu futur assess
result account method rather true earn
metric use use sever financial-stat base metric assess sustain
next page calcul detail detail avail appendix
vari significantli across compani due differ oper strategi
defer tax volatil standard deviat defer tax expens sale
overal score quintil rank ni adj ni quintil rank
adj ni quintil rank averag sustain score
exhibit adjust size rel adjust net incom yr total
 amort
note absolut valu adjust shown adjust advers impact adjust net incom compani profil slide detail
exhibit adjust percentag adjust net incom
rank analysi driven strong report qualiti cash convers
non-gaap adjust rank top tier report qualiti
non-gaap adjust except adjust impact tax reform dta
convert cash ep would impact amort neglig
peer cash flow gener rank second cash convers one year
past convers overal convert net incom
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
abbott rank middl tier improv last year directli compar given
materi recent acquisit
metric skew deal larg adjust driven recent deal skew metric across board
impact incom statement cash flow balanc sheet item
improv fourth tier year prior abbott rank skew signific
adjust st jude aler acquisit result abbott rank second lowest tier
improv mainli driven noa sale growth well adj ni improv
trough
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
baxter rank middl pack although directli compar given impact
spin drive ni adj ni ratio higher baxter report net gain retain
baxalta share drove ni adj ni ratio baxter rank report
qualiti exclud baxter would still rank top tier report qualiti
convers fell improv expect cash convers rank fourth
tier middl tier last year howev next year baxter move past low
expect metric improv move forward convers
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
bd maintain rank near middl despit qualiti impact larger acquisit carefus
bard
report qualiti impact signific amort charg adjust involv
 amort add-back includ inventori step-up adjust relat
purchas account relat cr bard acquisit ni adj ni fell
convers declin line peer median bd cash convers line
peer median fell given convers ratio fell vs prior averag
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
rank last analysi report qualiti cash convers
signific adjust result multitud acquisit boston bottom tier
compani term magnitud adjust frequent back larg impair charg
larg litig expens substanti amort adj ni past year
convers bottom tier boston cash convers ratio rank second lowest
analysi consist bottom tier rank recent year convers materi lower
due lower cash flow oper driven decreas liabil due pay
legal reserv accru incom tax
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
edward remain top tier earn qualiti driven larg part report qualiti
report qualiti cash convers remain top notch edward compani analysi
averag adj ni addit ni adj ni remain
averag non-gaap adjust larg immateri drive report qualiti higher
sustain metric fell edward sustain rank fell driven bottom tier rank
abnorm st accrual vs top tier rank year prior
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
globu rank near middl pack report qualiti strength weigh mid-
level cash convers lower sustain
top-tier report qualiti globu among lowest level non-gaap adjust
coverag given convert cash ep recent follow alphatec intern acquisit
limit one-tim charg litig repeat adjust account
adjust net incom aggreg
sustain fell second lowest tier sustain metric vari qualiti globu
stronger defer tax volatil weaker noa sale growth abnorm st accrual
signific chang year prior
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
grifol rank middl tier strong report qualiti off-set averag sustain
cash convers
earn qualiti cash convers stabl report qualiti rank unchang
cash convers remain middl pack non-gaap adjust
sustain improv continu lag peer grifol sustain rank improv vs
year prior remain second lowest tier improv deriv defer tax volatil
howev noa-sal growth accrual capital-expenditure depreci remain averag
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
haemonet rank rel stabl y/i remain fourth tier continu
restructur weigh report qualiti
heavi restructur larg adjust haemonet record signific restructur
charg past five fiscal year year restructur charg excess
adjust net incom
convers improv remain averag rank last cash
convers average improv year averag year move past ratio
although still peer median
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
avano bottom tier rank directli compar peer given impact spin
sale ip unit
spin asset sale pressur report qualiti avano rank last report qualiti
consist last year larg spin-driven restructur litig charg goodwil impair
 ip
sustain rebound fall avano drop rank
sustain move ip discontinu oper howev anniversari sale improv
gener sustain current rank although varianc metric remain wide
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
hill-rom rank second tier earn qualiti consist last year
flow convers rank drop remain averag hill-rom strong cash convers
rank drop move past strong adj net incom
recent year seen adjust given restructur
sustain metric remain strong hill-rom rank second tier sustain driven asset
replac ratio defer tax volatil although accrual rank fell vs peer
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
earn qualiti metric rank improv across board howev lower
report qualiti lag due signific impair charg cynosur signific impair
charg compani acquisit cynosur leav fourth tier report qualiti
report qualiti also averag due continu impair asset
convers improv top tier despit adjust rank cash convers
convert averag adj ni past year four includ
convers ratio signific gain sale blood screen busi caus neg ratio
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
intuit rank second tier driven cash convers report qualiti strength
convers remain strong intuit continu rank top tier cash convers
averag convers adj net incom past five year
sustain score declin fourth tier noa sale growth declin top tier rank last
year averag drive fourth tier rank vs second prior
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
johnson johnson rank top tier follow middl pack rank last year
report qualiti took slight step histor rank well report qualiti
averag adj net incom howev signific charg tax reform caus
rank fall continu amort litig charg result
improv averag
convers improv remain rel consist year cash
convers rank improv vs prior howev remain rang year sinc
rank improv year mainli driven peer median convers drop
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
rank fall analysi fourth tier vs top tier prior
convers sustain rank fell meaning convers ratio fell
lowest level record gain sale mitg busi drove cash flow lower
combin higher tax sustain metric declin larg due lower tier rank abnorm
st accrual defer tax volatil
report qualiti consist middl pack report qualiti trend
downward recent year increas non- adjust ni adj ni averag
mark lowest ratio sinc began track bring averag
line peer median
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
nuvas improv fourth tier vs bottom prior due improv sustain
averag report qualiti larger litig amort weigh nuvas rank
fourth tier report qualiti given larger amort litig adjust compani
stop back stock comp prior largest adjust would expect metric gradual
sustain improv metric mix sustain score improv middl
tier vs last tier prior due improv abnorm st accrual op accrual howev defer
tax volatil remain lowest tier
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
rank bottom tier cash convers sustain score materi lag
in-lin report qualiti skew due one-tim tax impact ni
 adj ni improv vs prior howev larg due signific tax impact
caus ratio improv exclud ratio would although
would remain second tier report qualiti
bottom tier rank sustain skew acquisit execut number
deal sinc physio novadaq entellu etc time close impact
balanc sheet incom statement metric use sustain calcul
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
rank top tier analysi driven meaning increas sustain score
abnorm st accrual noa sale growth score peer level anniversari
transact spark improv metric rank sustain vs prior
report qualiti consist y/i report qualiti score remain middl pack y/i
 amort remain signific part compani add-back
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
zimmer biomet averag earn qualiti rank pressur convers
biomet acquisit drove signific drop report qualiti convers
larger amort cost follow biomet deal recent restructur cost
pressur rank report qualiti cash convers addit qualiti remedi charg
due compani warsaw campu result recent one-tim charg
top tier rank sustain zimmer biomet rank sustain driven top tier rank
op accrual capital-expenditure depreci averag rank noa sale growth defer tax
exhibit earn
earn mm
exhibit sale noa growth
growth net op asset growth
price target base multipl base case
ep line high growth larg cap peer see
multipl reflect abbott better peer top bottom line growth nutrit
recov china imf headwind fade aler stabil gradual return market
growth new product libr confirm mri launch mitraclip
inflect sustain organ growth profil medium term management execut
deal synergi margin grow per year support ep
base case valuat use price-to-earnings valuat larg cap peer
believ justifi given better top bottom line growth line high
growth peer
valu driver includ continu oper margin expans core abbott
combin cost synergi execut st jude aler organ growth
acceler driven devic product launch diabet ep structur heart
risk price target includ emerg market macro slowdown fx headwind
strengthen us dollar failur deliv synergi target and/or growth
acceler aler failur libr mitraclip drive top-line growth
price target reflect multipl base case
sale multipl high growth devic peer support dcf
valuat assum wacc termin growth assum sale grow
driven continu impella penetr protect pci shock
risk pt includ failur demonstr sustain impella growth
call growth sustain question ii emerg competit ahead
expect market growth present attract opportun new entrant
pressur share price iii reimburs risk annual drg reimburs
variabl
deriv base case scenario price target base ebitda
discount back use ebitda normal cost
transform plan follow ip unit sale multipl discount peer
given lower organ growth partial off-set signific margin expans
opportun transform proce estim high avano grow
top-line low mid singl digit give headwind margin start lower
consensu appreci path toward margin improv move forward
risk price target includ top-line revenu grow upper singl digit signific
near-term recoveri on-q pain pump avano execut larg accret
price target reflect multipl base case
ebitda in-line peer given lower wamgr off-set margin expans
opportun assum organ growth margin reach
risk includ medic deliveri nutrit recov expect ii
potenti activ below- wacc return iii inabl gener oper
leverag iv baxter struggl grow wamgr
price target base multipl base case
ebitda premium peer organ growth improv becom
evid new product ramp cost program gain traction bard synergi
integr track bd/bard deal model drive mid-teen underli ep
risk price target includ integr fall behind schedul promis
synergi fail materi ii macro trend get wors competit pressur em
mount iii new product launch fail live expect
price target base multipl base case
ep assum trade larg cap peer justifi superior emerg
growth margin expans opportun leverag profil line high
growth peer ew sustain execut support
acceler high singl digit large-cap growth stori recent build pipelin
program drive sale compound-annual-growth-rate oper margin remain
track bp annual improv next sever year drive mid-teen
risk price target includ unfavor legal develop increas competit
core de market competit product launch failur execut
plan pipelin program integr
price target reflect ev sale multipl base
case sale line high growth smid cap devic compani
support dcf valuat assum wacc termin growth rate
risk price target includ guardian libr competit greater
expect limit new patient start materi increas attrit ii dexcom
traction medicar limit coverag guardian libr come sooner
expect iii libr forc signific price pressur limit path
profit delay failur pipelin catalyst
price target deriv discount cash flow model assum wacc
termin growth model project tavr market growth
billion drive ebit margin incorpor valu reflect
risk price target includ acceler competit
us near term robust commerci traction boston abbott/st jude
long term ii potenti pipelin develop failur mitral space
market opportun could larger aortic least sever year away iii
reimburs structur us europ could put downward pressur price
time
price target deriv discount cash flow valuat impli
core busi ebitda valu globu robot program
trauma launch
risk price target includ increas turnov among sale forc
lower iv robot uptak limit
price target adr assum class share trade one
year forward earn grifol histor turn premium european
pharma adr trade discount class share consist
averag valuat spread past sever year
risk price target includ narrow valuat spread adr vs class
share ii addit accret could drive upsid estim iii stabil
competit situat us ivig could support favor price trend
price target reflect ev/ebitda estim premium
upsid risk price target includ higher price benefit nexsi ii
identif addit cost opportun iii capit deploy downsid
risk includ nexsi disappoint ii cost save fail materi iii blood
bank slow materi iv teg disappoint
price target reflect ev/ebitda multipl discount
smid cap med-tech given leverag lower growth pipelin product move hill-rom
structur organ growth rate mid singl digit time compani execut
lrp emerg market begin inflect improv stabil growth visibl
margin improv drive multipl higher
risk price target includ pipelin traction slow fail materi
upcom product ii intern sale disappoint iii margin leverag prove
difficult iv materi shift capital-expenditure environ
price target base multipl base case
ebitda discount larg cap devic peer market satur
increas regul limit cynosur growth segment grow expect
growth rate increas competit surgic lead novasur declin breast
grow lsd-msd new product launch recent drive growth
diagnost price risk manag off-set panther placement
util deliv organ sale growth high singl digit ep growth
risk price target includ deploy capit enter faster growth end
market drive ep growth greater expect share buyback
synergi ii ccynosur recov faster anticip abl achiev doubl
digit growth profil iii novasur manag competit threat
price target reflect ev sale multipl base
case discount high growth smid cap peer ex us growth improv
meaning ypsome gross up near term disrupt fade us
growth remain stabl driven medicar shift pharmaci
mdi pediatr posit insul omnipod ap competitor risk
remain path sale pipelin product sustain growth
gm clear like floor dash roll horizon ap launch
base case reflect ev sale multipl discount
high growth smid cap peer
downsid risk includ insulet lose market share ap competitor ii limit
convers anima patient iii ypsome disrupt greater expect iv
dash horizon ap timelin slip path profit becom less clear upsid
risk includ minim disrupt ypsome transit ii disclosur
